Correlation Between DiaMedica Therapeutics and CG Oncology,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and CG Oncology, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and CG Oncology, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and CG Oncology, Common, you can compare the effects of market volatilities on DiaMedica Therapeutics and CG Oncology, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of CG Oncology,. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and CG Oncology,.

Diversification Opportunities for DiaMedica Therapeutics and CG Oncology,

-0.37
  Correlation Coefficient

Very good diversification

The 3 months correlation between DiaMedica and CGON is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and CG Oncology, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CG Oncology, Common and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with CG Oncology,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CG Oncology, Common has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and CG Oncology, go up and down completely randomly.

Pair Corralation between DiaMedica Therapeutics and CG Oncology,

Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 1.07 times more return on investment than CG Oncology,. However, DiaMedica Therapeutics is 1.07 times more volatile than CG Oncology, Common. It trades about 0.08 of its potential returns per unit of risk. CG Oncology, Common is currently generating about 0.0 per unit of risk. If you would invest  275.00  in DiaMedica Therapeutics on September 12, 2024 and sell it today you would earn a total of  241.00  from holding DiaMedica Therapeutics or generate 87.64% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy89.92%
ValuesDaily Returns

DiaMedica Therapeutics  vs.  CG Oncology, Common

 Performance 
       Timeline  
DiaMedica Therapeutics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in DiaMedica Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, DiaMedica Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.
CG Oncology, Common 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CG Oncology, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, CG Oncology, is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

DiaMedica Therapeutics and CG Oncology, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with DiaMedica Therapeutics and CG Oncology,

The main advantage of trading using opposite DiaMedica Therapeutics and CG Oncology, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, CG Oncology, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CG Oncology, will offset losses from the drop in CG Oncology,'s long position.
The idea behind DiaMedica Therapeutics and CG Oncology, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments